Although increasing evidence has demonstrated the role of miR-21 in several types of liver diseases [12], only one study indicates the potential association between NAFLD, HCC and miR-21 via the interaction with the Hbp1-p53-Srebp1c pathway [8]. This evidence concerns the gene SREBF1 and hepatocellular carcinoma.